Paper Review Records
全部论文审稿周期
25 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
9
天
Undetectable Hydroxyurea Levels in the Majority of Sickle Cell Disease Patients, Especially in Young Children
作者
Sigrid van der Veen; Bart J. Biemond; Marjon H. Cnossen; Pablo Bartolucci; Maria P. Boaro; Betzabel Cajiao Garcia; Raffaella Colombatti; M. D'Agnolo; Karin Fijnvandraat; Anna Collado Gimbert; Amira Idrizovic; Petros Kountouris; Mar Mañú‐Pereira; Elisabetta Mezzalira; Mariane de Montalembert; Erfan Nur; A. Pham Hung D' Alexandry D'Orengiani; Tiziana Sanavia; Saskia E. M. Schols; Marissa J. M. Traets; Minke A. E. Rab; Sara I. Reidel; Anita W. Rijneveld; Yosr Zaouali; Nanda M. Verhoeven‐Duif; Judith J. M. Jans; Eduard J. van Beers展开收起
作者单位
1. Center for Benign Hematology, Thrombosis and Hemostasis – Van Creveldkliniek, University Medical Center Utrecht, Utrecht University Utrecht the Netherlands; 2. Section Metabolic Diagnostics, Department of Genetics University Medical Centre Utrecht, Utrecht University Utrecht the Netherlands; 3. Department of Hematology Amsterdam University Medical Center Amsterdam the Netherlands; 4. Department of Pediatric Hematology and Oncology, Erasmus MC ‐ Sophia Children's Hospital Erasmus University Medical Center Rotterdam Rotterdam the Netherlands; 5. University Paris‐Est‐Créteil, IMRB, Inserm U955, Henri Mondor University Hospitals, APHP, Sickle Cell Referral Center‐UMGGR Creteil France; 6. UOC Oncoematologia Pediatrica, Azienda Ospedale‐Università Padova Padua Italy; 7. Department of Women's and Children's Health University of Padua Padua Italy; 8. Department of Pediatric Hematology Amsterdam UMC, Emma Children's Hospital Amsterdam the Netherlands; 9. Sanquin Research, Department of Molecular Cellular Hemostasis Amsterdam the Netherlands; 10. Rare Anemia Research Laboratory, Vall D'hebron Institut de Recerca Barcelona Spain; 11. Pediatric Oncology and Hematology Department Hospital Universitari Vall D'hebron Barcelona Spain; 12. Genetics and Microbiology Department Universitat Autonoma de Barcelona Barcelona Spain; 13. Molecular Genetics Thalassaemia Department The Cyprus Institute of Neurology and Genetics Nicosia Cyprus; 14. Department of General Pediatrics and Pediatric Infectious Diseases Sickle Cell Center, Necker‐Enfants Malades Hospital Neuilly France; 15. Department of Blood Cell Research Sanquin Research and Landsteiner Laboratory Amsterdam the Netherlands; 16. AI and Computational Biomedicine Unit, Department of Medical Sciences University of Torino Turin Italy; 17. Department of Hematology Radboud University Medical Center Nijmegen the Netherlands; 18. Central Diagnostic Laboratory ‐ Research, University Medical Center Utrecht Utrecht the Netherlands; 19. Department of Hematology Erasmus University Medical Center Rotterdam the Netherlands展开收起
67
天
High Proportion of PNH Type II Neutrophils Is Associated With Thrombosis in Patients Displaying a PNH Clone ≥ 1%
作者
Orianne Wagner‐Ballon; Anne‐Catherine Lhoumeau; Anna Raimbault; Camille Debord; Jean‐Philippe Vial; Valérie Soenen; Mélanie Pannetier; Edouard Bonneville; Elsa Bera; Caroline Bret; Nicolas Chapuis; Véronique Latger‐Cannard; Caroline Mayeur‐Rousse; Véronique Harrivel; François Vergez; Marie Loosveld; Juliette Vo Xuan; Stéphanie Mathis; Gérard Socié; Flore Sicre de Fontbrune; Régis Peffault de Latour; Bernard Drenou; Agathe Debliquis; Magali Le Garff‐Tavernier; the French PNH working group CytHem‐HPN展开收起
作者单位
1. Département Hématologie et Immunologie Biologiques APHP Hôpitaux Universitaires Henri Mondor Créteil France; 2. Université Paris‐Est Créteil (UPEC), Inserm U955 IMRB Créteil France; 3. Institut Paoli Calmettes, Laboratoire de Biopathologie Marseille France; 4. APHP Hôpital Saint Louis, Service Hématologie Biologique Paris France; 5. CHU Nantes, Laboratoire Hématologie Nantes France; 6. CHU Bordeaux, Laboratoire Hématologie Bordeaux France; 7. CHU Lille, Laboratoire Hématologie Lille France; 8. CHU de Rennes, Laboratoire Hématologie Rennes France; 9. CHU Grenoble, Laboratoire Hématologie Grenoble France; 10. CHU Rouen, Laboratoire Hématologie Rouen France; 11. CHU Montpellier, Laboratoire Hématologie Montpellier France; 12. APHP CHU Cochin, Laboratoire Hématologie Paris France; 13. CHU Nancy, Laboratoire Hématologie Nancy France; 14. CHU Strasbourg, Laboratoire Hématologie Strasbourg France; 15. CHU Amiens, Laboratoire Hématologie Amiens France; 16. CHU Toulouse, Laboratoire Hématologie Toulouse France; 17. CHU Timone, Laboratoire Hématologie Marseille France; 18. APHP Hôpital Saint Louis, Service Hématologie Clinique Paris France; 19. Groupe Hospitalier de la Région Mulhouse Sud Alsace Service Hématologie Clinique Mulhouse France; 20. Groupe Hospitalier de la Région Mulhouse Sud Alsace Laboratoire Hématologie Mulhouse France; 21. APHP Groupe Hospitalier Pitié‐Salpêtrière‐Charles Foix, Sorbonne Université Service D'hématologie Biologique Paris France; 22. Centre de Recherche Des Cordeliers, Sorbonne Université, Université Paris Cité, Inserm UMRS 1138 Drug Resistance in Hematological Malignancies Team Paris France展开收起
61
天
Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN / HMA
作者
Fieke W. Hoff; Joshua F. Zeidner; Geeta Torlapati; Deedra Nicolet; Krzysztof Mrózek; Ying Huang; Alexander Li; Rina Li Welkie; Ronan T. Swords; Elie Traer; Eytan M. Stein; Tara L. Lin; Maria R. Baer; Vu H. Duong; William G. Blum; Martha L. Arellano; Wendy Stock; Olatoyosi Odenike; Rebecca L. Olin; Catherine C. Smith; Gary J. Schiller; Emily K. Curran; Onyee Chan; Christine McMahon; Michael Hochman; Kieran Sahasrabudhe; Charles Foucar; Jesus Gonzalez‐Lugo; Brittany Knick Ragon; Shivani V. Handa; Nyla A. Heerema; Timothy Chen; Molly Martycz; Mona Stefanos; Sonja G. Marcus; Leonard Rosenberg; Brian J. Druker; Ross L. Levine; Amy Burd; Ashley O. Yocum; Uma M. Borate; Alice S. Mims; Ann‐Katrin Eisfeld; John C. Byrd; Yazan F. Madanat展开收起
作者单位
1. National Heart, Lung, and Blood Institute National Institutes of Health Bethesda Maryland USA; 2. Division of Hematology, Department of Medicine, Lineberger Comprehensive Cancer Center University of North Carolina Chapel Hill North Carolina USA; 3. The James Cancer Hospital The Ohio State University Columbus Ohio USA; 4. Clara D. Bloomfield Center for Leukemia Outcomes Research The Ohio State University Comprehensive Cancer Center Columbus Ohio USA; 5. Department of Internal Medicine University of Texas Southwestern Medical Center Dallas Texas USA; 6. Division of Hematology and Medical Oncology, Knight Cancer Institute Oregon Health & Science University Portland Oregon USA; 7. Leukemia Service, Department of Medicine, Human Oncology and Pathogenesis Program Memorial Sloan Kettering Cancer Center New York New York USA; 8. Division of Hematologic Malignancies University of Kansas Medical Center Kansas City Kansas USA; 9. Department of Medicine University of Maryland Greenebaum Comprehensive Cancer Center Baltimore Maryland USA; 10. Department of Hematology and Medical Oncology Winship Cancer Institute of Emory University Atlanta Georgia USA; 11. Section of Hematology/Oncology University of Chicago Chicago Illinois USA; 12. Division of Hematology and Oncology University of California, San Francisco San Francisco California USA; 13. Department of Medicine, Hematology/Oncology David Geffen School of Medicine at University of California, Los Angeles Los Angeles California USA; 14. Division of Hematology & Oncology University of Cincinnati Cincinnati Ohio USA; 15. Malignant Hematology Department H. Lee Moffitt Cancer Center Tampa Florida USA; 16. Division of Hematology, Department of Medicine University of Colorado School of Medicine Aurora Colorado USA; 17. Division of Hematology University of Wisconsin, Carbone Cancer Center Madison Wisconsin USA; 18. Department of Internal Medicine, Division of Hematology and Oncology University of New Mexico Albuquerque New Mexico USA; 19. Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine Charlotte North Carolina USA; 20. Blood Cancer United Washington DC USA; 21. UPMC Hillman Cancer Center University of Pittsburgh Pittsburgh Pennsylvania USA展开收起
83
天
Comparative Efficacy of Intranasal, Intramuscular, and Intravenous Vitamin B12 Therapy for Hematological Recovery in Vitamin B12 Deficiency Anemia: A Randomized Controlled Trial
作者
Santosh Kumar Singh; Rahil Arora; Suman Kumar Pramanik; Abhishek Kumar; Alok Singh; Shantanu Khanna; Nitya Malhotra; Pranay Juneja; Netri Upadhyay; Uday Yanamandra展开收起
作者单位
1. Department of Internal Medicine Armed Forces Medical College (AFMC) Pune India; 2. Department of Medical Research Armed Forces Medical College (AFMC) Pune India; 3. Department of Medicine Military Hospital Kirkee Pune India; 4. Department of Radiology Command Hospital, Air Force Bangalore India; 5. Department of Medicine, Government Medical College and Hospital Chandigarh India; 6. Department of Medicine, JNMC, DMIHER Wardha India展开收起
30
天
Clinical Predictors of Response in Chronic Graft‐Versus‐Host Disease: Results From the “Predicting the Quality of Response to Specific Treatments ( PQRST )” Trial
作者
Betty K. Hamilton; Lynn Onstad; Paul A. Carpenter; Joseph Pidala; George Chen; Corey Cutler; Najla El Jurdi; Nosha Farhadfar; Mark Juckett; Carrie L. Kitko; Catherine J. Lee; Stephanie J. Lee展开收起
作者单位
1. Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology Taussig Cancer Institute, Cleveland Clinic Cleveland Ohio USA; 2. Clinical Research Division Fred Hutchinson Cancer Center Seattle Washington USA; 3. H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA; 4. University of Texas MD Anderson Cancer Center Houston Texas USA; 5. Dana Farber Cancer Institute Boston Massachusetts USA; 6. National Cancer Institute, National Institutes of Health Bethesda Maryland USA; 7. Sarah Cannon Transplant and Cellular Program, Methodist Hospital San Antonio Texas USA; 8. University of Minnesota Minneapolis Minnesota USA; 9. Vanderbilt University Medical Center Nashville Tennessee USA展开收起
236
天
Relapse Thresholds (12/24 Mo) Define Survival Disparity in Pediatric B‐ ALL
作者
Binjun Xiong; Jianwen Zhou; Xuhan Zhang; Yance Feng; Jie Cheng; Hui Shi; Qian Li; Wenli Tang; Yali Shen; Fen Zhou; Shaoyan Hu; Hua You展开收起
作者单位
1. Precision Oncology and Intelligent Theranostics Laboratory Children's Hospital of Chongqing Medical University Chongqing China; 2. Ministry of Education Key Laboratory of Child Development and Disorders National Clinical Research Center for Children and Adolescents' Health and Diseases Chongqing China; 3. Department of Hematology and Oncology Children's Hospital Affiliated to Zhengzhou University (Zhengzhou Children's Hospital) Zhengzhou China; 4. Division of Life Sciences and Medicine, Department of Pediatric Hematology and Oncology The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), University of Science and Technology of China Hefei China; 5. Department of Hematology and Oncology Anhui Provincial Children's Hospital Hefei China; 6. Department of Pediatric Hematology and Oncology Children's Hospital of Chongqing Medical University Chongqing China; 7. Department of Pediatrics Union Hospital, Tongji Medical College of Huazhong University of Science and Technology Wuhan China; 8. Department of Hematology and Oncology Children's Hospital of Soochow University Suzhou China; 9. Department of Pediatric Oncology Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China Chengdu China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天